NEUROONE MEDICAL TECHNOLOGIE (NMTC) Stock Analyst Ratings
USA - NASDAQ:NMTC - US64130M2098 - Common Stock
0.7185 USD
-0.01 (-1.82%)
0.7185 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 85% to NMTC. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 2.27. This target is 215.87% above the current price.
NMTC was analyzed by 8 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about NMTC.
In the previous month the buy percentage consensus was at a similar level.
NMTC was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-09 | Maxim Group | Initiate | Buy |
| 2025-05-05 | Ladenburg Thalmann | Initiate | Buy |
| 2023-08-15 | Alliance Global Partners | Maintains | Buy -> Buy |
| 2021-12-03 | Alliance Global Partners | Initiate | Buy |
| 2021-11-15 | Craig-Hallum | Initiate | Buy |
NEUROONE MEDICAL TECHNOLOGIE / NMTC FAQ
What is the price target for NMTC stock?
8 analysts have analysed NMTC and the average price target is 2.27 USD. This implies a price increase of 215.87% is expected in the next year compared to the current price of 0.7185.
What is the consensus rating for NMTC stock?
The consensus rating for NEUROONE MEDICAL TECHNOLOGIE (NMTC) is 85 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed NEUROONE MEDICAL TECHNOLOGIE (NMTC)?
The number of analysts covering NEUROONE MEDICAL TECHNOLOGIE (NMTC) is 8.